[Skip to Content]
[Skip to Content Landing]

September 2019 - July 1959

Decade

Year

Issue

June 2015, Vol 72, No. 6, Pages 620-729

In This Issue of JAMA Neurology

Highlights

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):620. doi:10.1001/jamaneurol.2014.2851
Viewpoint

Neurology and the Affordable Care Act

Abstract Full Text
JAMA Neurol. 2015;72(6):623-624. doi:10.1001/jamaneurol.2015.0083

This Viewpoint reports on the effect of the Affordable Care Act on US health care, specifically with regard to neurology.

Political Correctness of Medical Documentation

Abstract Full Text
JAMA Neurol. 2015;72(6):624-625. doi:10.1001/jamaneurol.2014.4535

This Viewpoint discusses the use of racial and other descriptors in medical histories.

Editorial

The Human Alzheimer Disease Project: A New Call to Arms

Abstract Full Text
JAMA Neurol. 2015;72(6):626-628. doi:10.1001/jamaneurol.2015.67

Cognition and Quality-of-Life Outcomes in the Targeted Temperature Management Trial for Cardiac Arrest

Abstract Full Text
JAMA Neurol. 2015;72(6):628-630. doi:10.1001/jamaneurol.2015.0164

Unraveling the Enigma of Seronegative Myasthenia Gravis

Abstract Full Text
JAMA Neurol. 2015;72(6):630-631. doi:10.1001/jamaneurol.2015.0205

Status Epilepticus: Redefined or Increasingly Detected?

Abstract Full Text
JAMA Neurol. 2015;72(6):631-633. doi:10.1001/jamaneurol.2015.0204
Original Investigation

Clinical Trial

Neurologic Function and Health-Related Quality of Life in Patients Following Targeted Temperature Management at 33°C vs 36°C After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):634-641. doi:10.1001/jamaneurol.2015.0169

This multicenter randomized clinical trial found good quality of life in patients with cardiac arrest receiving targeted temperature management.

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):642-649. doi:10.1001/jamaneurol.2015.0203

This cohort study determines the diagnostic usefulness of cell-based assays in the diagnosis of myasthenia gravis and compares the clinical features of patients with antibodies only to clustered acetylcholine receptors with those of patients with seronegative myasthenia gravis. See the Editorial by Vernino.

Trends in Status Epilepticus—Related Hospitalizations and Mortality: Redefined in US Practice Over Time

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):650-655. doi:10.1001/jamaneurol.2015.0188

This retrospective study of patients with status epilepticus demonstrated that status epilepticus–related mortality remained relatively steady from 1999 to 2010, but the rate of hospitalizations for status epilepticus increased significantly in the same period.

Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):656-665. doi:10.1001/jamaneurol.2015.0202

This longitudinal observational study investigates the usefulness of CSF VILIP-1, tau, p-tau181, and Aβ42 levels in predicting rates of whole-brain and regional atrophy in early AD and cognitively normal control subjects over time.

Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):666-675. doi:10.1001/jamaneurol.2015.0178

This review of oxidative metabolism in biopsy samples finds that an altered regulation of myogenesis and a downregulated mitochondrial biogenesis contribute to pathologic change in the muscle of patients with spinal muscular atrophy.

Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):676-681. doi:10.1001/jamaneurol.2015.48

This case-control study suggests that an amyotrophic lateral sclerosis syndrome might be associated with autoimmunity and gluten sensitivity.

Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)–Reykjavik Study

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):682-688. doi:10.1001/jamaneurol.2015.0174

This population-based brain imaging study finds similar risk factors for intracerebral hemorrhage and cerebral microbleeds (CMBs), with a distinction between lobar and deep CMBs, in a sample of people older than 65 years.

Association of a Novel ACTA1 Mutation With a Dominant Progressive Scapuloperoneal Myopathy in an Extended Family

Abstract Full Text
free access has multimedia
JAMA Neurol. 2015;72(6):689-698. doi:10.1001/jamaneurol.2015.37

This observational genetics study identifies a new scapuloperoneal phenotype associated with an ACTA1 mutation.

Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):699-706. doi:10.1001/jamaneurol.2015.0098

This cross-sectional cohort study investigates whether cognitive reserve modifies the adverse influence of age on key cerebrospinal fluid biomarkers of Alzheimer disease in a cognitively normal group and a cognitively impaired group.

Review

Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease

Abstract Full Text
JAMA Neurol. 2015;72(6):707-712. doi:10.1001/jamaneurol.2014.4563

This review provides an overview of rapid eye movement sleep disorder from the onset of dream enactment through the emergence of a parkinsonian disorder.

Brain Stimulation for Torsion Dystonia

Abstract Full Text
JAMA Neurol. 2015;72(6):713-719. doi:10.1001/jamaneurol.2015.51

This review reports that patients with dystonia that is not adequately controlled with standard medical therapy should be referred for consideration of deep brain stimulation.

Images in Neurology

Basilar Artery Aneurysm in a Woman With Syphilis

Abstract Full Text
JAMA Neurol. 2015;72(6):720-721. doi:10.1001/jamaneurol.2015.0154
Observation

A New Association Between Castleman Disease and Immune-Mediated Cerebellitis

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):722-723. doi:10.1001/jamaneurol.2015.0091
Comment & Response

Glucocerebrosidase Gene Mutation and Preclinical Markers of Parkinson Disease

Abstract Full Text
JAMA Neurol. 2015;72(6):723-724. doi:10.1001/jamaneurol.2015.0487

Glucocerebrosidase Gene Mutation and Preclinical Markers of Parkinson Disease—Reply

Abstract Full Text
JAMA Neurol. 2015;72(6):724. doi:10.1001/jamaneurol.2015.0484

Diagnosing Encephalitis, Not Otherwise Specified

Abstract Full Text
JAMA Neurol. 2015;72(6):725. doi:10.1001/jamaneurol.2015.0542

Diagnosing Encephalitis, Not Otherwise Specified

Abstract Full Text
JAMA Neurol. 2015;72(6):725-726. doi:10.1001/jamaneurol.2015.0545

Diagnosing Encephalitis, Not Otherwise Specified—Reply

Abstract Full Text
JAMA Neurol. 2015;72(6):726-727. doi:10.1001/jamaneurol.2015.0548
Obituary

In Memoriam: Jean Lindenmann (1924-2015): A Circuitous Interfering Power in Neurology

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):728-729. doi:10.1001/jamaneurol.2015.0439
JAMA Neurology Masthead

JAMA Neurology

Abstract Full Text
free access
JAMA Neurol. 2015;72(6):620. doi:10.1001/jamaneurol.2014.2852
×